HDIM
QGENF

Hanson & Doremus Investment Management’s QIAGEN NV QGENF Stock Holding History

Hanson & Doremus Investment Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-100
Closed -$2.8K – 495
2016
Q4 		$2.8K Hold
100
– – ﹤0.01% 438
2016
Q3 		$3K Hold
100
– – ﹤0.01% 431
2016
Q2 		$2K Hold
100
– – ﹤0.01% 430
2016
Q1 		$2K Hold
100
– – ﹤0.01% 447
2015
Q4 		$3K Hold
100
– – ﹤0.01% 449
2015
Q3 		$3K Hold
100
– – ﹤0.01% 428
2015
Q2 		$2K Hold
100
– – ﹤0.01% 435
2015
Q1 		$3K Hold
100
– – ﹤0.01% 443
2014
Q4 		$2K Hold
100
– – ﹤0.01% 443
2014
Q3 		$2K Hold
100
– – ﹤0.01% 421
2014
Q2 		$2K Hold
100
– – ﹤0.01% 412
2014
Q1 		$2K Hold
100
– – ﹤0.01% 415
2013
Q4 		$2K Hold
100
– – ﹤0.01% 421
2013
Q3 		$2K Hold
100
– – ﹤0.01% 394
2013
Q2 		$2K Buy
+100
New +$2K ﹤0.01% 358

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Hanson & Doremus Investment Management's QGENF Position: Q1 2017 in Review

Hanson & Doremus Investment Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 100 shares — an estimated $2.8K sold.

Hanson & Doremus Investment Management first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $3K in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Hanson & Doremus Investment Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 100 QIAGEN NV shares in Q1 2017, an estimated $2.8K.
  • Hanson & Doremus Investment Management first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Hanson & Doremus Investment Management's QIAGEN NV position peaked at $3K in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2017, filed 15 May 2017.